Linda Bachman, APRN
Psychiatric/Mental Health · Nashua, NHNPI 1619161395
Payments from drug & device makers
Across 55 payments — averaging $16.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$263
- Lundbeck LLC$149
- Alkermes, Inc.$122
- Otsuka America Pharmaceutical, Inc.$91
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$82
- Takeda Pharmaceuticals U.S.A., Inc.$48
- plus $146 from 4 others
What the payments were for
- Food & beverage$85295%
- Education$495%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $263 |
| Lundbeck LLC | 9 | $149 |
| Alkermes, Inc. | 7 | $122 |
| Otsuka America Pharmaceutical, Inc. | 5 | $91 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Johnson & Johnson | 3 | $40 |
| Vanda Pharmaceuticals Inc. | 2 | $38 |
| Sunovion Pharmaceuticals Inc. | 2 | $38 |
| Neurocrine Biosciences, Inc. | 2 | $30 |
How this compares
$901 in reported general payments places this provider in the 65th percentile of 264 psychiatric/mental health providers in New Hampshire.
See all psychiatric/mental health providers in New Hampshire →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 26 | $1,812 |
| Duloxetine Hcl | 33 | $628 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 17 | $407 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 12 | $383 |
| Lamotrigine | 30 | $296 |
| Bupropion XlBupropion Hcl | 20 | $279 |
| Buspirone Hcl | 21 | $259 |
| Aripiprazole | 13 | $222 |
| Quetiapine Fumarate | 13 | $220 |
| Clonazepam | 27 | $216 |
| Sertraline Hcl | 22 | $204 |
| Alprazolam | 29 | $151 |
| Mirtazapine | 15 | $142 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 16 | $124 |
| Lorazepam | 26 | $113 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Nashua
- Nancy GilbertNashua$58K
- Chengping WangNashua$11K
- Katherine BrockNashua$3K
- Susan VonderheideNashua$3K
- Yara HenningerNashua$3K
- Mertie PotterNashua$3K
- Jennifer PennNashua$2K
- Tuyet NguyenNashua$2K
- Christine IsabelleNashua$2K
- Christina FarnworthNashua$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.